Cargando…

Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats

STUDY OBJECTIVES: Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Raymond, Joel S, Everett, Nicholas A, Gururajan, Anand, Bowen, Michael T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334738/
https://www.ncbi.nlm.nih.gov/pubmed/37039749
http://dx.doi.org/10.1093/sleep/zsad112
_version_ 1785070920349515776
author Raymond, Joel S
Everett, Nicholas A
Gururajan, Anand
Bowen, Michael T
author_facet Raymond, Joel S
Everett, Nicholas A
Gururajan, Anand
Bowen, Michael T
author_sort Raymond, Joel S
collection PubMed
description STUDY OBJECTIVES: Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness. However, as oxytocin can attenuate stress, reduce activity, and elicit anxiolysis, oxytocin might also prime the brain for rest, and promote sleep. At present, little research has comprehensively characterized the neuropsychopharmacology of oxytocin-induced effects on sleep–wake behavior and no reconciliation of these two competing hypotheses has been proposed. METHODS: This study explored the effects of oxytocin on sleep–wake outcomes using radiotelemetry-based polysomnography in adult male and female Wistar rats. Oxytocin was administered via intraperitoneal (i.p.; 0.1, 0.3 and 1 mg·kg(−1)) and intranasal (i.n.; 0.06, 1, 3 mg·kg(−1)) routes. Caffeine (i.p. and i.n.; 10 mg·kg(−1)) was administered as a wake-promoting positive control. To ascertain mechanism of action, pretreatment experiments with the oxytocin receptor (OXTR) antagonist L-368,899 (i.p.; 5 mg·kg(−1)) followed by oxytocin (i.p.; 1 mg·kg(−1)) were also conducted. RESULTS: In both male and female rats, i.p. oxytocin promoted quiet wakefulness at the cost of suppressing active wakefulness, non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Several i.p. oxytocin-induced sleep–wake effects were mediated by OXTR binding. In contrast, i.n. oxytocin did not alter most sleep–wake outcomes at any dose tested. Both i.p. and i.n. caffeine demonstrated wake-promoting effects. CONCLUSIONS: These findings help reconcile competing hypotheses of oxytocin-induced effects on sleep–wake behavior: i.p. oxytocin promotes quiet wakefulness—a state of restful environmental awareness compatible with both oxytocin’s anxiolytic effects and its enhancement of processing complex stimuli.
format Online
Article
Text
id pubmed-10334738
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103347382023-07-12 Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats Raymond, Joel S Everett, Nicholas A Gururajan, Anand Bowen, Michael T Sleep Basic Science of Sleep and Circadian Rhythms STUDY OBJECTIVES: Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness. However, as oxytocin can attenuate stress, reduce activity, and elicit anxiolysis, oxytocin might also prime the brain for rest, and promote sleep. At present, little research has comprehensively characterized the neuropsychopharmacology of oxytocin-induced effects on sleep–wake behavior and no reconciliation of these two competing hypotheses has been proposed. METHODS: This study explored the effects of oxytocin on sleep–wake outcomes using radiotelemetry-based polysomnography in adult male and female Wistar rats. Oxytocin was administered via intraperitoneal (i.p.; 0.1, 0.3 and 1 mg·kg(−1)) and intranasal (i.n.; 0.06, 1, 3 mg·kg(−1)) routes. Caffeine (i.p. and i.n.; 10 mg·kg(−1)) was administered as a wake-promoting positive control. To ascertain mechanism of action, pretreatment experiments with the oxytocin receptor (OXTR) antagonist L-368,899 (i.p.; 5 mg·kg(−1)) followed by oxytocin (i.p.; 1 mg·kg(−1)) were also conducted. RESULTS: In both male and female rats, i.p. oxytocin promoted quiet wakefulness at the cost of suppressing active wakefulness, non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Several i.p. oxytocin-induced sleep–wake effects were mediated by OXTR binding. In contrast, i.n. oxytocin did not alter most sleep–wake outcomes at any dose tested. Both i.p. and i.n. caffeine demonstrated wake-promoting effects. CONCLUSIONS: These findings help reconcile competing hypotheses of oxytocin-induced effects on sleep–wake behavior: i.p. oxytocin promotes quiet wakefulness—a state of restful environmental awareness compatible with both oxytocin’s anxiolytic effects and its enhancement of processing complex stimuli. Oxford University Press 2023-04-11 /pmc/articles/PMC10334738/ /pubmed/37039749 http://dx.doi.org/10.1093/sleep/zsad112 Text en © Sleep Research Society 2023. Published by Oxford University Press on behalf of the Sleep Research Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Basic Science of Sleep and Circadian Rhythms
Raymond, Joel S
Everett, Nicholas A
Gururajan, Anand
Bowen, Michael T
Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title_full Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title_fullStr Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title_full_unstemmed Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title_short Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
title_sort quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
topic Basic Science of Sleep and Circadian Rhythms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334738/
https://www.ncbi.nlm.nih.gov/pubmed/37039749
http://dx.doi.org/10.1093/sleep/zsad112
work_keys_str_mv AT raymondjoels quietwakefulnesstheinfluenceofintraperitonealandintranasaloxytocinonsleepwakebehaviorandneurophysiologyinrats
AT everettnicholasa quietwakefulnesstheinfluenceofintraperitonealandintranasaloxytocinonsleepwakebehaviorandneurophysiologyinrats
AT gururajananand quietwakefulnesstheinfluenceofintraperitonealandintranasaloxytocinonsleepwakebehaviorandneurophysiologyinrats
AT bowenmichaelt quietwakefulnesstheinfluenceofintraperitonealandintranasaloxytocinonsleepwakebehaviorandneurophysiologyinrats